Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company’s diagnostic products in development include the lymphocyte proli... Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company’s diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer’s disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with multiple sclerosis. Its therapeutic products in development comprise Eltoprazine, a small molecule drug for the treatment of Parkinson’s disease Levadopa-Induced Dyskinesia and attention deficit hyperactivity disorders; and mesencephalic-astrocyte-derived neurotrophic factor for the treatment of various animal models, including retinitis pigmentosa and retinal artery occlusion. It also develops NuroPro, a neurodegenerative disease diagnostic platform with application in Parkinson’s disease; BC-SeraPro, an oncology diagnostic platform with application in breast cancer; and PhenoGuard platform for neurrotrophic factor discovery. In addition, the company develops Engineered Skin Substitute (ESS), a cell therapy-based autologous skin replacement product that is in mid-stage clinical development for the treatment of life-threatening severe burns. Amarantus BioScience Holdings, Inc. has a cooperative research and development agreement with the U.S. Army Institute of Surgical Research and Rutgers University. The company was formerly known as Amarantus Bioscience, Inc. and changed its name to Amarantus BioScience Holdings, Inc. in April 2013. Amarantus BioScience Holdings, Inc. was founded in 2008 and is headquartered in New York, New York. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 25903 | 1.0E-6 | CS |
| 12 | 0 | 0 | 1.0E-6 | 0.25 | 1.0E-6 | 996779 | 5.37E-6 | CS |
| 26 | 0 | 0 | 1.0E-6 | 0.25 | 1.0E-6 | 656728 | 4.83E-6 | CS |
| 52 | 0 | 0 | 1.0E-6 | 0.25 | 1.0E-6 | 411491 | 1.257E-5 | CS |
| 156 | -0.000749 | -99.8666666667 | 0.00075 | 0.25 | 1.0E-6 | 681540 | 0.00068495 | CS |
| 260 | -0.008599 | -99.988372093 | 0.0086 | 0.25 | 1.0E-6 | 1635277 | 0.00441398 | CS |
longboardsurfer90210
1年前
jFrank1
1年前
MattyTrader
1年前
lasombra
1年前
freegriff
2年前
to6908
2年前
Lolo12
2年前
lasombra
2年前
Judah137
2年前
MattyTrader
2年前
MattyTrader
2年前
lasombra
2年前
velcro
2年前
velcro
2年前
lasombra
2年前
Lolo12
3年前
Lolo12
3年前
MattyTrader
3年前
freegriff
3年前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。